Paul Rutgeerts

Researcher Next ID · RN-007570

Researcher · Biochemistry, Genetics and Molecular Biology

Leuven, Belgium

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Inflammatory Bowel Disease

Microscopic Colitis

Autoimmune and Inflammatory Disorders

Helicobacter pylori-related gastroenterology studies

Rheumatoid Arthritis Research and Therapies

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1215734
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0904492
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050516
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)08512-4
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
New England Journal of Medicine · 1997 · https://doi.org/10.1056/nejm199710093371502

No projects listed.